Publications

Selected Publications

X Li, S Hufnagel, H Xu, SA Valdes, SG Thakkar, Z Cui, H Celio, Aluminum (oxy)hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity. ACS Applied Materials & Interfaces (2017), 9(27):22893-22901.

HL O’Mary, AM Aldayel, SA Valdes, YW Naguib, K Salvady, Z Cui, Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model. Molecular Pharmaceutics (2017) 14(6):1929-1937.

X Li, YW Naguib, S Valdes, S Hufnagel, Z Cui, Reverse microemulsion-based synthesis of (bis)phosphonate-metal materials with controllable physical properties: An example using zoledronic acid-calcium complexes. ACS Applied Materials & Interfaces (2017) 9(16):14478-14489.

AM Aldayel, YW Naguib, HL O’Mary, X Li, M Niu, TB Ruwona, Z Cui, Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-alpha siRNA in chronic inflammation sites. Molecular Therapy – Nucleic Acids (2016) 5(7):e340.

YW Naguib, D Lansakara-P., LM Lashinger, BL Rodriguez, S Valdes, M Niu, AM Aldayel, L Peng, SD Hursting, Z Cui, Synthesis, characterization, and in vitro and in vivo evaluations of 4-(N)-docosahexaenoyl 2’2’-difluorodeoxycytidine with potent and broad spectrum antitumor activity. Neoplasia, (2016), 18(1):33-38.

X Li, S Thakkar, TB Ruwona, RO Williams III, Z Cui, A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. Journal of Controlled Release (2015), 204:38-50.

X Li, AM Aldayel, Z Cui, Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. Journal of Controlled Release (2014) 173: 148-57.

S Zhu, M Niu, HL O’Mary, Z Cui, Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Molecular Pharmaceutics (2013) 10 (9): 3525-30.

BL Rodriguez JM Blando, DS Lansakara-P., Y Kiguchi, J DiGiovanni, Z Cui, Antitumor activity of tumor-targeting RNA replicase-based plasmid that express interleukin-2 in a murine melanoma model. Molecular Pharmaceutics (2013) 10 (6): 2404-15.

P Wongana, DS Lansakara-P., S Zhu, M Holzer, MA Sandoval, M Warthaka, Z Cui, Just getting into cells is not enough: Mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle’s ability to overcome gemcitabine resistance caused by RRM1 overexpression. Journal of Controlled Release (2013) 169 (1-2): 17-27.

A Kumar, P Wonganan, MA Sandoval, X Li, S Zhu, and Z Cui, Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. Journal of Controlled Release (2012) 163 (2): 230-9.

WG Chung, MA Sandoval, BR Sloat, DSP Lansakara-P., Z Cui, Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase M1. Journal of Controlled Release (2012) 157(1): 132-40.

For a complete list of publications, please search on www.pubmed.gov.


Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy